Swift Biosciences
Launch date
Market cap
-
Enterprise valuation
$49—73m (Dealroom.co estimates Jun 2017.)
Ann Arbor Michigan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$3.0m | Series A | ||
| N/A | $500k | Early VC | |
$7.0m | Series B | ||
| N/A | $1.5m | Debt | |
| N/A | $3.0m | Series C | |
$12.2m | Series D | ||
| N/A | $4.0m | Debt | |
N/A | Acquisition | ||
| Total Funding | $25.7m | ||
Recent News about Swift Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.